Geographical distribution
B. caballi and B. equi are frequently associated because they share common vectors. However, infections with B. equi are more prevalent than B. caballi infections. Both infections are widespread throughout tropical and subtropical zones, but B. caballi infections extend far more to the north. The African continent as a whole is highly endemic for B. equi. Our sero-epidemiological studies have shown that in Zaire and in the Sudan virtually all horses are infected with B. equi. Similar results were reported for zebras in East Africa by Young and Purnell (17) . While B. caballi infections are very common in the Sudan, such infections were not identified in Zaire. Thus, the geographical distribution of B. caballi in Africa south of the Sahara requires further investigation.
Equine babesioses are probably endemic throughout Asia except Siberia. High infection rates have been reported from the Near and Middle East and from India (5) . Recent reports indicate that B. equi and B. caballi are common in China (9) and in Korea. However, autochthonous infections obviously do not occur on the Japanese islands (16) .
In Europe, equine babesioses extend from Portugal and Spain, through France and Italy to the whole of the Balkan peninsula, and from there to the southern and central parts of the European Soviet Union. Autochthonous infections probably do not occur in Germany, Austria and Switzerland north of the Alpine mountain range, although some vector ticks (Dermacentor species) are endemic in this area. The same is true for England and Wales where Dermacentor reticulatus occurs.
In the forest belt of central Russia, B. caballi infections extend as far north as the 58th degree of latitude. This is the distribution area of Dermacentor reticulatus, an important vector tick.
Australia is the only continent where equine Babesia has not become established, although B. equi was introduced with imported horses in 1976. There was some spread of the infection, probably by contamination of injection needles or other instruments with blood. These foci could be extinguished because suitable vector ticks were obviously absent.
In the New World, both equine Babesia species are highly endemic in Latin America with the exception of the southern parts of Chile and Argentina. Almost all horses examined from Colombia and Brazil were seropositive for B. equi, and nearly as many for B. caballi. Horses in these countries are often heavily infested with ticks. Similar reports have been published for nearly all Latin American countries ranging from Cuba to Argentina. In the New World, the only known vector is the one-host tick Dermacentor (Anocentor) nitens, the so-called tropical horse tick. However, Dermacentor albipictus, the winter tick, may be another vector, as shown experimentally (14) . Altogether, 13 tick species of the genera Dermacentor, Hyalomma and Rhipicephalus have been incriminated as vectors of B. caballi. This accounts for the high incidence and wide distribution of this parasite in the equine population. However, almost nothing is known of the transmission of B. caballi in the tropics and the Southern Hemisphere. In Latin America, the highly abundant D. nitens is probably the principal vector.
B. equi is known to be transmitted in the Old World by at least eight tick species of the genera Dermacentor, Hyalomma and Rhipicephalus (4) . No vector is known for B. equi in the New World, even though this parasite infects most of the horses in Latin America, as indicated above.
B. equi is usually acquired by nymphs and transmitted by both male and female adults. Single male ticks can transmit B. equi to several horses because of their longevity and mobility. Hyalomma males, for instance, may infest horses or other hosts for several weeks or even months. This facilitates the spread of infection.
B. equi is highly infective for nymphs of Hyalomma anatolicum and Rhipicephalus turanicus: 85% to 92% of the nymphs may acquire infection despite low parasitaemia. Up to 17 acini of the salivary glands become infected in the ensuing adult ticks. Many thousands of sporozoites are produced in a single acinus cell.
Nymphs of two tick species have become infected by feeding on a horse that was negative in the complement fixation (CF) test. These ticks transmitted B. equi to other horses in the adult stage. Hence, even CF-negative horses may constitute a source of infection for suitable vector ticks (Friedhoff et al., unpublished data).
Epidemiology
There are few reports on severe outbreaks, although several have been reported in India (12) , as were several others during the Second World War. In general, acute disease is uncommon in endemic areas.
There have been a few outbreaks in the USA, Germany and Switzerland without tick vectors being involved. In these disease-free areas, B. equi had been transmitted by the use of contaminated needles or instruments. It may be concluded that a horse may remain infected with B. equi for many years, perhaps for life. The authors also conclude that ticks can acquire the infection while feeding on infected horses which are negative to the CF test. Thus, infected horses are the reservoir of infection with B. equi, but not the vector ticks, because there is no transovarial but only stage-tostage transmission. On the other hand B. caballi infections are self-terminating, usually limited to 1-3 years. It is not known whether ticks can acquire infection from seronegative or from latently infected horses. It appears that horses are infective for ticks only during the rather short period of a latent B. caballi infection. Thus, ticks, rather than horses, are the reservoir of infection with B. caballi because the infection may persist in ticks throughout several generations, with trans-stadial and transovarial transmission.
During the last ten years there have been several studies of the prevalence of equine babesiosis in various countries, as revealed by serodiagnosis using the CF test and the indirect immunofluorescent antibody (IFA) test. Results obtained at the Central Veterinary Laboratory at Weybridge and at the Hanover Veterinary School during the last ten years, together with other sources of information, have led to the following conclusions:
Equine babesioses are not endemic in Ireland, the United Kingdom, the Netherlands, the Scandinavian countries and Germany. Belgium, Switzerland, Austria, the CSFR and Poland are probably marginal areas where autochthonous infections may occur. Most infections of horses examined in England and Germany have been traced back to Spain, France, Italy and the Soviet Union.
Spreading of the infections from marginal into disease-free areas (e. In the Old World, tick infestation rates appear to be low in most countries. Dermacentor species are more common at the northern boundary of the distribution area and in marginal areas, whereas Hyalomma and Rhipicephalus ticks predominate in southern Europe, North Africa and the Near and Middle East, including India and the southern regions of the Soviet Union.
There is a potential risk of Dermacentor, Rhipicephalus
and Hyalomma species becoming established in the New World or in Australia, if these ticks are introduced with horses or other hosts.
Control
Control of the equine babesioses depends on the epidemiological situation. In disease-free areas, tickborne infections do not occur. The only sources of infection are the introduction of infected equines or ticks, and the transmission of disease by blood-contaminated instruments.
Thus, control measures are directed mainly against the importation of infected equines, e.g. into the USA, Canada, Australia, Japan and certain other countries. There are no such restrictions in Germany, the Netherlands, Denmark and other European countries. The authorities of the latter countries have evidently decided that the spread of babesia infections cannot occur. This assumption is based on the historical experience that, throughout centuries of unrestricted horse traffic, no foci of tickborne infections have become established.
All countries take measures to prevent the introduction of ticks; however, this is an almost impossible task. During the past 25 years, numerous tick species have been introduced into Germany with domestic, zoo or other exotic animals.
Hyalomma,
Rhipicephalus and Dermacentor species from the Old World could become established in the New World and the American tropical horse tick in the Old World. There is certainly constant risk of the introduction of potential vector ticks into the New World (1). The consequences of the spreading of ticks are much worse than the introduction of infected horses. The potential distribution of vector ticks can be estimated by using the climatic matching programme ("CLIMAX") of Sutherst and Maywald (15) .
In marginal areas, eradication should be attempted. Again, this is a difficult task. Since the first outbreak of equine piroplasmosis in Florida in 1959, control measures have not achieved eradication of B. caballi.
In endemic areas, there have been attempts to protect stud farms or military horses, e.g. in the Soviet Union and in India. As far as we know, these attempts have been unsuccessful to date, with a few exceptions. However, strict isolation of horses and intensive tick control are extremely expensive. Complete tick control is impossible in larger endemic areas.
Control measures have been quite unsatisfactory up to now, for the following reasons:
1. There is no drug that eliminates B. equi infections. It has been claimed that treatment with imidocarb derivatives can eliminate B. equi infections. From our experience, four doses of imidocarb diproprionate in the toxic dosage range of 6-8 mg/kg body weight may reduce CF titres. Such horses may become CF-negative for a few weeks or months, but remain positive in the IFA test and -more importantly -they remain infective for vector ticks.
2. The CF test does not identify all infected horses. The proportion of these falsenegative CF reactions tends to increase when horses have been treated before testing. Therefore, we recommend an additional IFA test whenever horses have been outside a country such as Germany, or have been in close contact with seropositive horses.
Thus, there is an urgent need for:
1. A non-toxic drug that eliminates B. equi infections.
A serological test that allows safe identification of an infection. This test should
give negative results a few weeks after elimination of the infection. Furthermore, such a test should be capable of standardisation. Test results achieved in various laboratories must agree, otherwise horse owners and agencies involved in the transportation of horses will loose confidence in the reliability and usefulness of expensive control measures and severe restrictions. Contradictory test results from a European laboratory and the official testing agency in the USA or Canada may cause expenses of 20,000 US dollars for a single horse.
In cooperation with colleagues at Weybridge, the authors recently succeeded in cultivating the erythrocytic stages of B. caballi and B. equi in vitro. This opens the possibility of testing drugs in vitro and producing antigens from cultures for the development of a suitable test.
3. Finally, no vaccines against B. equi or B. caballi infections are available to protect horses shipped into endemic areas.
Ehrlichia infections
The genus Ehrlichia belongs to the order Rickettsiales. Ehrlichia species parasitise the leukocytes or other cells of some mammals, including man. During the acute clinical disease, loosely-packed rickettsias are observed to form morulae or inclusion bodies in the cytoplasm.
Two species have been identified in horses: Ehrlichia equi, which parasitises in neutrophil and eosinophil granulocytes, and the recently described Ehrlichia risticii, which parasitises macrophages, mast cells and deep glandular epithelial cells in the lamina propria and submucosa of the large colon; also, to a lesser extent, macrophages of the small colon and of other organs, and blood monocytes (3).
The experimental host range of E. equi includes donkeys, sheep, goats, dogs, cats and monkeys, but clinical disease has been observed only in horses and donkeys. The disease is characterised by fever, depression, anorexia, ataxia, limb oedema, leukopenia, thrombocytopenia and mild anaemia. Equine granulocytic ehrlichiosis was observed at first in California in 1969 (13, 7) but later also in other states of the USA. In 1984, the disease was observed in a horse that had never been outside Germany (2) . In the meantime, two additional cases of equine granulocytic ehrlichiosis were reported from Switzerland (8) , and the infection was identified in 4 other horses (6) . Thus, 7 cases have been reported from central Europe to date. Ehrlichia risticii is the etiologic agent of equine monocytic ehrlichiosis, also known as Potomac horse fever or equine ehrlichial colitis, a recently recognised disease of horses characterised by fever, depression, diarrhoea and leukopenia. Several days after the acute phase of the disease, about 30% of the affected animals exhibit other signs, such as colic, oedema of the legs and ventral abdomen, and laminitis. Some horses may develop profound ileus and severe colic (10) . Mortality rates are approximately 25%.
Gross lesions from field cases include ulceration of the glandular and pyloric regions of the stomach, patchy congestion of the duodenum, caecum, anterior and middle colon, with watery contents in these organs. Multifocal areas of necrosis in mucous membranes were observed in experimentally infected horses (3).
Potomac horse fever has been confirmed in at least 17 states in the USA and in Ontario.
Control of the equine ehrlichioses faces some difficulties.
1. Tetracyclines are recommended for treating acute ehrlichiosis. Early treatment is important in Potomac horse fever. However, tetracyclines exacerbate diarrhoea caused by Salmonella, and may cause "antibiotic-associated diarrhoea". Therefore, a rapid diagnostic test is needed to provide an early diagnosis. PALABRAS CLAVE: Distribución geográfica -Enfermedades de los équidos -Enfermedades propagadas por garrapatas -Infecciones por rickettsiasIxodidae -Profilaxis -Protozoosis -Vectores. * * *
